Experienced in Acute Intermittent Porphyria

Dr. Michael T. Pulley

University Of Florida Jacksonville Physicians, Inc.
St Mary's, GA
Experienced
in Acute Intermittent Porphyria
Specialties:Neurology
Accepting New Patients
Offers Telehealth
OverviewInsuranceLocationsClinical Research

Overview

Michael Pulley is a Neurologist in St Mary's, Georgia. Dr. Pulley and is rated as an Experienced provider by MediFind in the treatment of Acute Intermittent Porphyria. His top areas of expertise are Myasthenia Gravis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal Muscular Atrophy (SMA), and Thymectomy. Dr. Pulley is currently accepting new patients.

His clinical research consists of co-authoring 19 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Acute Intermittent Porphyria.

Specialties
Neurology
Licenses
Psychiatry & Neurology in FL
Hospital Affiliations
Shands Jacksonville
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Health Options
  •  CareSource
  •  Humana
  •  Florida Blue

Locations

UNIVERSITY OF FLORIDA JACKSONVILLE PHYSICIANS, INC.
2000 Dan Proctor Dr, St Mary's, GA 31558
912-729-6821
Other Locations
UNIVERSITY OF FLORIDA JACKSONVILLE PHYSICIANS, INC.
655 W 8th St, Jacksonville, FL 32209
904-244-3950

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
Enrollment Status: Completed
Publish Date: December 12, 2024
Phase 2B Study of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
Phase 2B Study of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
Enrollment Status: Completed
Publish Date: November 29, 2022
Intervention Type: Drug
Study Drug: Memantine
Study Phase: Phase 2
Fluid Biomarkers With Deep Phenotyping in Patients With ALS
Fluid Biomarkers With Deep Phenotyping in Patients With ALS
Enrollment Status: Completed
Publish Date: December 16, 2021
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of lGIV-C as a Corticosteroid Sparing Agent in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of lGIV-C as a Corticosteroid Sparing Agent in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
Enrollment Status: Completed
Publish Date: March 30, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) in Symptomatic Subjects With Generalized Myasthenia Gravis
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Immune Globulin (Human), 10% Caprylate/Chromatography Purified (IGIV-C) in Symptomatic Subjects With Generalized Myasthenia Gravis
Enrollment Status: Completed
Publish Date: March 05, 2019
Intervention Type: Drug
Study Phase: Phase 2
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Enrollment Status: Completed
Publish Date: July 06, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 5 Less Clinical Trials

18 Total Publications

A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis.
A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis.
Journal: Muscle & nerve
Published: November 28, 2023
Similar Doctors
Expertise in
23
conditions
Dr. David R. Chabolla
Neurology
Expertise in
23
conditions
Dr. David R. Chabolla
Neurology

St Vincent's Ambulatory Care Inc

4205 Belfort Rd, 
Jacksonville, FL 
 (36.5 mi)
904-308-7959
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Chabolla is a Neurologist in Jacksonville, Florida. Dr. Chabolla and is rated as a Distinguished provider by MediFind in the treatment of Acute Intermittent Porphyria. His top areas of expertise are Memory Loss, Seizures, Hereditary Sensory and Autonomic Neuropathy Type 2, and Infantile Axonal Neuropathy. Dr. Chabolla is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile